199 related articles for article (PubMed ID: 18684915)
1. Cutting edge: in vivo trogocytosis as a mechanism of double negative regulatory T cell-mediated antigen-specific suppression.
Ford McIntyre MS; Young KJ; Gao J; Joe B; Zhang L
J Immunol; 2008 Aug; 181(4):2271-5. PubMed ID: 18684915
[TBL] [Abstract][Full Text] [Related]
2. Consequences of double negative regulatory T cell and antigen presenting cell interaction on immune response suppression.
Ford McIntyre MS; Gao JF; Li X; Naeini BM; Zhang L
Int Immunopharmacol; 2011 May; 11(5):597-603. PubMed ID: 21109036
[TBL] [Abstract][Full Text] [Related]
3. Regulation of antigen-expressing dendritic cells by double negative regulatory T cells.
Gao JF; McIntyre MS; Juvet SC; Diao J; Li X; Vanama RB; Mak TW; Cattral MS; Zhang L
Eur J Immunol; 2011 Sep; 41(9):2699-708. PubMed ID: 21660936
[TBL] [Abstract][Full Text] [Related]
4. Double-negative T regulatory cells can develop outside the thymus and do not mature from CD8+ T cell precursors.
Ford MS; Zhang ZX; Chen W; Zhang L
J Immunol; 2006 Sep; 177(5):2803-9. PubMed ID: 16920915
[TBL] [Abstract][Full Text] [Related]
5. Role of double-negative regulatory T cells in long-term cardiac xenograft survival.
Chen W; Ford MS; Young KJ; Cybulsky MI; Zhang L
J Immunol; 2003 Feb; 170(4):1846-53. PubMed ID: 12574350
[TBL] [Abstract][Full Text] [Related]
6. Presentation of acquired peptide-MHC class II ligands by CD4+ regulatory T cells or helper cells differentially regulates antigen-specific CD4+ T cell response.
Zhou G; Ding ZC; Fu J; Levitsky HI
J Immunol; 2011 Feb; 186(4):2148-55. PubMed ID: 21242518
[TBL] [Abstract][Full Text] [Related]
7. Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen.
Schulz RJ; Parkes A; Mizoguchi E; Bhan AK; Koyasu S
J Immunol; 1996 Nov; 157(10):4379-89. PubMed ID: 8906813
[TBL] [Abstract][Full Text] [Related]
8. The role and mechanisms of double negative regulatory T cells in the suppression of immune responses.
Chen W; Ford MS; Young KJ; Zhang L
Cell Mol Immunol; 2004 Oct; 1(5):328-35. PubMed ID: 16285891
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of graft-versus-host disease by double-negative regulatory T cells.
Young KJ; DuTemple B; Phillips MJ; Zhang L
J Immunol; 2003 Jul; 171(1):134-41. PubMed ID: 12816991
[TBL] [Abstract][Full Text] [Related]
10. Mouse NK1.1+ cytotoxic T cells can be generated by IL-2 exposure from lymphocytes which express an intermediate level of T cell receptor.
Ikarashi Y; Maruoka H; Shinohara K; Sugimura T; Terada M; Wakasugi H
Immunol Lett; 1998 Apr; 61(2-3):165-73. PubMed ID: 9657270
[TBL] [Abstract][Full Text] [Related]
11. Enhanced tumor responses to dendritic cells in the absence of CD8-positive cells.
Ribas A; Wargo JA; Comin-Anduix B; Sanetti S; Schumacher LY; McLean C; Dissette VB; Glaspy JA; McBride WH; Butterfield LH; Economou JS
J Immunol; 2004 Apr; 172(8):4762-9. PubMed ID: 15067052
[TBL] [Abstract][Full Text] [Related]
12. Involvement of NK1+ CD4- CD8- alphabeta T cells and endogenous IL-4 in non-MHC-restricted rejection of embryonal carcinoma in genetically resistant mice.
Nakamura E; Kubota H; Sato M; Sugie T; Yoshida O; Minato N
J Immunol; 1997 Jun; 158(11):5338-48. PubMed ID: 9164954
[TBL] [Abstract][Full Text] [Related]
13. Pretransplant infusion of donor B cells enhances donor-specific skin allograft survival.
Gao J; McIntyre MS; D'Souza CA; Zhang L
PLoS One; 2013; 8(10):e77761. PubMed ID: 24204953
[TBL] [Abstract][Full Text] [Related]
14. Enhanced suppression of polyclonal CD8
Mu C; Zhang X; Wang L; Xu A; Ahmed KA; Pang X; Chibbar R; Freywald A; Huang J; Zhu Y; Xiang J
J Leukoc Biol; 2017 May; 101(5):1221-1231. PubMed ID: 28096300
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the immunoregulatory function of human TCR-αβ+ CD4- CD8- double-negative T cells.
Voelkl S; Gary R; Mackensen A
Eur J Immunol; 2011 Mar; 41(3):739-48. PubMed ID: 21287552
[TBL] [Abstract][Full Text] [Related]
16. Alloantigen specific T regulatory cells in transplant tolerance.
Hall BM; Tran G; Hodgkinson SJ
Int Immunopharmacol; 2009 May; 9(5):570-4. PubMed ID: 19539571
[TBL] [Abstract][Full Text] [Related]
17. Liver CD4-CD8- NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro.
Pied S; Roland J; Louise A; Voegtle D; Soulard V; Mazier D; Cazenave PA
J Immunol; 2000 Feb; 164(3):1463-9. PubMed ID: 10640763
[TBL] [Abstract][Full Text] [Related]
18. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells.
Blank C; Brown I; Marks R; Nishimura H; Honjo T; Gajewski TF
J Immunol; 2003 Nov; 171(9):4574-81. PubMed ID: 14568931
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of allogeneic cytotoxic T cell (CD8
Kang N; Toyofuku WM; Yang X; Scott MD
Acta Biomater; 2017 Jul; 57():146-155. PubMed ID: 28442414
[TBL] [Abstract][Full Text] [Related]
20. TCR-mediated target cell lysis by CD4+NK1+ liver T lymphocytes.
Emoto M; Emoto Y; Kaufmann SH
Int Immunol; 1997 Apr; 9(4):563-71. PubMed ID: 9138017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
